Clinical Trials Directory

Trials / Completed

CompletedNCT06368024

Establishment of Delphi-MD Safety Performance and Reliability

Status
Completed
Phase
Study type
Observational
Enrollment
263 (actual)
Sponsor
QuantalX Neuroscience · Industry
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

A retrospective analysis of collected datasets. In this study we aim to establish Delphi-MD's safety and performance reliability for assessment and monitoring of Transcranial Magnetic Stimulation (TMS) Evoked Potentials (TEPs) as neurophysiological measurements.

Detailed description

A retrospective analysis of collected datasets. In this study we aim to establish Delphi-MD's safety and reliability for assessment and monitoring of TEP's as neurophysiological measurements. Safety: Upper limit of the 95% CI of the device related serious adverse event (SAE) rate is less than or equal to 3.6% Performance: Demonstrate differentiation of relevant clinical groups Reliability: An acceptable mean Interclass correlation (ICC) statistic (six stimulation) is at least 0.6 Additionally, the within subject variability should be lower than the between subject variability.

Conditions

Interventions

TypeNameDescription
OTHERThis is a retrospective analysis study of data collected with a diagnostic medical deviceTranscranial Magnetic stimulation and Electroencephalogram

Timeline

Start date
2023-11-28
Primary completion
2023-11-28
Completion
2023-11-28
First posted
2024-04-16
Last updated
2024-04-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT06368024. Inclusion in this directory is not an endorsement.